DLX3 | Distal-less homeobox 3 | Disease related genes Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
DLX4 | Distal-less homeobox 4 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
DPRX | Divergent-paired related homeobox | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
ENPP1 | Ectonucleotide pyrophosphatase/phosphodiesterase 1 | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ERVMER34-1 | Endogenous retrovirus group MER34, member 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
FAM124B | Family with sequence similarity 124B | Predicted intracellular proteins
| | | | | Tissue enhanced |
FAM162B | Family with sequence similarity 162, member B | Predicted membrane proteins
| | | | | Tissue enhanced |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GDF15 | Growth differentiation factor 15 | Cancer-related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
GJA3 | Gap junction protein, alpha 3, 46kDa | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJA4 | Gap junction protein, alpha 4, 37kDa | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
GJA5 | Gap junction protein, alpha 5, 40kDa | Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
GJB7 | Gap junction protein, beta 7, 25kDa | Predicted membrane proteins
| | | | | Tissue enhanced |
GLDC | Glycine dehydrogenase (decarboxylating) | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GPC3 | Glypican 3 | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR1 | G protein-coupled receptor 1 | G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GPR50 | G protein-coupled receptor 50 | G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GRAMD2 | GRAM domain containing 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
GUCY1A2 | Guanylate cyclase 1, soluble, alpha 2 | Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
GYLTL1B | Glycosyltransferase-like 1B | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
HACE1 | HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1 | Disease related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
HAPLN1 | Hyaluronan and proteoglycan link protein 1 | Predicted secreted proteins
| | | | | Tissue enhanced |
HES2 | Hes family bHLH transcription factor 2 | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HIF3A | Hypoxia inducible factor 3, alpha subunit | Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
HIGD1B | HIG1 hypoxia inducible domain family, member 1B | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HLA-G | Major histocompatibility complex, class I, G | Cancer-related genes Predicted membrane proteins
| | | | | Tissue enhanced |
HPGDS | Hematopoietic prostaglandin D synthase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
HSD17B2 | Hydroxysteroid (17-beta) dehydrogenase 2 | Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
HSPA6 | Heat shock 70kDa protein 6 (HSP70B') | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
HTR1B | 5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
HYAL4 | Hyaluronoglucosaminidase 4 | Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
IDO1 | Indoleamine 2,3-dioxygenase 1 | Cancer-related genes Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
IGF2BP3 | Insulin-like growth factor 2 mRNA binding protein 3 | Predicted intracellular proteins
| | | | | Tissue enhanced |
IGSF5 | Immunoglobulin superfamily, member 5 | Predicted membrane proteins
| | | | | Tissue enhanced |
IL12RB2 | Interleukin 12 receptor, beta 2 | Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ISM1 | Isthmin 1, angiogenesis inhibitor | Predicted secreted proteins
| | | | | Tissue enhanced |
ISYNA1 | Inositol-3-phosphate synthase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ITIH5 | Inter-alpha-trypsin inhibitor heavy chain family, member 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
KANK4 | KN motif and ankyrin repeat domains 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
KDR | Kinase insert domain receptor (a type III receptor tyrosine kinase) | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins RAS pathway related proteins
| | | | | Tissue enhanced |
KLF14 | Kruppel-like factor 14 | Predicted intracellular proteins
| | | | | Tissue enhanced |
LAIR2 | Leukocyte-associated immunoglobulin-like receptor 2 | CD markers Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMA2 | Laminin, alpha 2 | Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LAMC3 | Laminin, gamma 3 | Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
LGR5 | Leucine-rich repeat containing G protein-coupled receptor 5 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
LYPD6 | LY6/PLAUR domain containing 6 | Predicted secreted proteins
| | | | | Tissue enhanced |
LYVE1 | Lymphatic vessel endothelial hyaluronan receptor 1 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
MAP1LC3C | Microtubule-associated protein 1 light chain 3 gamma | Predicted intracellular proteins
| | | | | Tissue enhanced |
MATN3 | Matrilin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |